Latest news
Stay up to date
Receive updates on new technology developments, market and industry trends, special events, Mayo Clinic technologies available for licensing, and more.
Mayo Clinic News Network | May 9, 2023
StarTribune | April 28, 2023
EXCERPT: Spun out of Mayo Clinic in 2018, Marani Health is piloting an in-home prenatal and postpartum care system that uses an artificial intelligence application for measuring the heart rates of pregnant women and their unborn fetus.
Mayo Clinic YouTube | April 17, 2023
The featured technology is now part of Anumana, a company formed by Mayo Clinic and nference, that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.
PR Newswire | April 11, 2023
Post Bulletin | April 7, 2023
Vyriad is a biotech firm founded by Mayo Clinic researchers.
Becker's Hospital Review | April 6, 2023
EXCERPT: Since 1986, when Mayo Clinic started keeping records, more than 7,000 inventors have disclosed 10,000 technologies (of which 4,000+ have been licensed to companies) and more than 300 startups have formed.
Post Bulletin | April 3, 2023
Businesswire | March 13, 2023
Mayo Clinic Discovery's Edge | March 3, 2023
In 2019, Mayo Clinic and W. L. Gore & Associates formed a collaboration to advance the development of implantable cell therapies to treat debilitating conditions with no cure. Based on early research, the innovative investigational treatment is now showing real promise for patients.
Star Tribune | March 1, 2023
EXCERPT: While Mayo Clinic remains the region’s largest employer, the Rochester area has become a draw for biomedical companies in recent years.Â
Mayo Clinic Individualized Medicine blog | February 27, 2023
Mayo Clinic executed a know-how license agreement with Maggie’s Pearl in 2021 to develop the first platform therapy for a group of related genetic inborn errors of metabolism called PMM2-CDG.
Post Bulletin | February 27, 2023
EXCERPT: Cytotheryx, co-founded by Exemplar Genetics and Mayo Clinic in 2018, announced that it has picked up the intellectual property assets of Ambys Medicines, Inc.
Becker's Hospital Review | February 22, 2023
Clark C. Otley, M.D., is the Chief Medical Officer for Mayo Clinic Platform and the Medical Director for Mayo Clinic’s Department of Business Development.
Startland News | February 20, 2023
Mayo Clinic Individualized Medicine blog | February 16, 2023
Adaptive Phage Therapeutics entered into an agreement with Mayo Clinic to commercialize a phage susceptibility test in June 2020.
MinnPost | February 14, 2023
EXCERPT: Minnesota, Olmsted County and the City of Rochester have committed $585 million over 20 years to stimulate an anticipated $5.6 billion of private investment that leverages Mayo Clinic’s legacy to make Rochester a global destination for health and wellness.
PR Web | February 2, 2023
Forbes Healthcare | February 1, 2023
Because of the federated architecture, Mayo Clinic Platform partners can safely leverage deidentified data from a single, centralized place while accounting for data privacy, security and access rights.
Becker's Healthcare | January 12, 2023
EXCERPT: Mayo Clinic and Kaiser Permanente were part of a $110 million funding round for Medically Home in January 2022 after becoming joint strategic investors the previous May.
Mayo Clinic Laboratories | January 10, 2023
Post Bulletin | January 6, 2023
EXCERPT: Mayo Clinic Chief Business Development Officer Jim Rogers spoke to highlight Mayo Clinic’s innovation, citing the launch or involvement with 32 startup companies in 2022 as well as that Mayo inventors have been issued 232 patents.Â